Guardion Health Sciences prices downsized $5 million IPO at $4
Guardion Health Sciences, which sells medical food and devices for retinal diseases, raised $5 million by offering 1.25 million shares at $4.
Guardion Health Sciences plans to list on the NYSE under the symbol GHSI. WallachBeth Capital and WestPark Capital acted as lead managers on the deal.
The article Guardion Health Sciences prices downsized $5 million IPO at $4 originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.